GlassScriptPhysician profile
Treasure Barnes
NPI 1265123822
$728.82
in general payments reported to CMS, 2019-2025
15 companies · $43.16 in 2025
The $43.16 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $149 · 2024: $537 · 2025: $43.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $140.68 | 2024 | Inspire |
| Edwards Lifesciences Corporation | $109.50 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.83 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $75.32 | 2023-2024 | Farxiga |
| Novo Nordisk INC | $65.86 | 2024 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $45.01 | 2023 | Jynarque |
| Ani Pharmaceuticals, INC. | $34.49 | 2024 | Purified Cortrophin Gel |
| Aurinia Pharma U.S., INC. | $29.50 | 2024 | Lupkynis |
| Boston Scientific Corporation | $27.19 | 2025 | Watchman Flx |
| Opko Pharmaceuticals, LLC | $24.25 | 2024 | Rayaldee |
| Lilly USA, LLC | $20.72 | 2023 | Mounjaro |
| Exact Sciences Corporation | $19.20 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $17.65 | 2023 | |
| Amgen INC. | $15.97 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.65 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Treasure Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.